Log in

NYSE:IVCInvacare Stock Price, Forecast & News

$6.42
-0.03 (-0.47 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.27
Now: $6.42
$6.63
50-Day Range
$5.89
MA: $6.72
$8.13
52-Week Range
$3.90
Now: $6.42
$11.63
Volume242,800 shs
Average Volume447,563 shs
Market Capitalization$221.01 million
P/E RatioN/A
Dividend Yield0.78%
Beta1.18
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators; and Invacare HomeFill oxygen systems. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
Read More
Invacare logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.41 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP46120310
Phone440-329-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$927.96 million
Cash Flow$0.10 per share
Book Value$8.20 per share

Profitability

Net Income$-53,330,000.00

Miscellaneous

Employees3,900
Market Cap$221.01 million
Next Earnings Date8/3/2020 (Estimated)
OptionableOptionable

Receive IVC News and Ratings via Email

Sign-up to receive the latest news and ratings for IVC and its competitors with MarketBeat's FREE daily newsletter.

Invacare (NYSE:IVC) Frequently Asked Questions

How has Invacare's stock been impacted by COVID-19 (Coronavirus)?

Invacare's stock was trading at $6.05 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IVC shares have increased by 6.1% and is now trading at $6.42. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Invacare?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Invacare.

When is Invacare's next earnings date?

Invacare is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Invacare.

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) released its quarterly earnings results on Wednesday, May, 6th. The health services provider reported ($0.21) EPS for the quarter, topping the Zacks' consensus estimate of ($0.22) by $0.01. The health services provider had revenue of $218.44 million for the quarter, compared to analyst estimates of $218 million. Invacare had a negative net margin of 4.19% and a negative return on equity of 10.17%. View Invacare's earnings history.

How often does Invacare pay dividends? What is the dividend yield for Invacare?

Invacare declared a quarterly dividend on Thursday, February 20th. Stockholders of record on Friday, April 3rd will be given a dividend of $0.0125 per share on Friday, April 17th. This represents a $0.05 dividend on an annualized basis and a yield of 0.78%. The ex-dividend date is Thursday, April 2nd. View Invacare's dividend history.

What guidance has Invacare issued on next quarter's earnings?

Invacare updated its first quarter 2020 Pre-Market earnings guidance on Tuesday, April, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $218-218 million, compared to the consensus revenue estimate of $222.51 million.

What price target have analysts set for IVC?

2 Wall Street analysts have issued 1 year price targets for Invacare's stock. Their forecasts range from $11.00 to $17.00. On average, they expect Invacare's share price to reach $14.00 in the next year. This suggests a possible upside of 118.1% from the stock's current price. View analysts' price targets for Invacare.

Has Invacare been receiving favorable news coverage?

Press coverage about IVC stock has trended negative recently, InfoTrie Sentiment reports. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Invacare earned a daily sentiment score of -2.1 on InfoTrie's scale. They also gave media headlines about the health services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news about Invacare.

Are investors shorting Invacare?

Invacare saw a drop in short interest in June. As of June 30th, there was short interest totaling 5,330,000 shares, a drop of 23.0% from the June 15th total of 6,920,000 shares. Based on an average daily trading volume, of 430,100 shares, the short-interest ratio is presently 12.4 days. Approximately 16.3% of the company's stock are sold short. View Invacare's Current Options Chain.

Who are some of Invacare's key competitors?

What other stocks do shareholders of Invacare own?

Who are Invacare's key executives?

Invacare's management team includes the following people:
  • Mr. Matthew E. Monaghan, Chairman, Pres & CEO (Age 51)
  • Ms. Kathleen P. Leneghan, Sr. VP & CFO (Age 56)
  • Mr. Anthony C. LaPlaca, Sr. VP, Gen. Counsel & Sec. (Age 61)
  • Ms. Darcie L. Karol, Sr. VP of HR (Age 52)
  • Mr. Ralf A. Ledda, Sr. VP & GM of EMEA (Age 51)

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

How do I buy shares of Invacare?

Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Invacare's stock price today?

One share of IVC stock can currently be purchased for approximately $6.42.

How big of a company is Invacare?

Invacare has a market capitalization of $221.01 million and generates $927.96 million in revenue each year. The health services provider earns $-53,330,000.00 in net income (profit) each year or ($1.06) on an earnings per share basis. Invacare employs 3,900 workers across the globe.

What is Invacare's official website?

The official website for Invacare is www.invacare.com.

How can I contact Invacare?

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44035. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected]

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.